Related Experiment Videos
Procainamide elimination kinetics in pediatric patients
Insights
Pediatric pharmacokinetics of procainamide show a short elimination half-life and rapid clearance. Continuous intravenous infusion may be needed to maintain therapeutic procainamide levels in children.
Area of Science:
- Pharmacology
- Pediatric Pharmacokinetics
- Drug Metabolism
Background:
- Understanding drug kinetics in children is crucial for safe and effective treatment.
- Procainamide is an antiarrhythmic drug with varying pharmacokinetic profiles across age groups.
Purpose of the Study:
- To characterize the pharmacokinetic parameters of procainamide in pediatric patients.
- To evaluate the formation and levels of N-acetylprocainamide (NAPA) in children receiving procainamide.
Main Methods:
- Intravenous administration of procainamide to six pediatric patients.
- Two-compartment kinetic analysis of serum concentration-time data.
- Measurement of procainamide and N-acetylprocainamide (NAPA) serum concentrations.
Main Results:
- Procainamide exhibited a short elimination half-life (1.7 +/- 0.1 hr) and rapid plasma clearance (19.4 +/- 2.0 ml/min/kg) in children.
- N-acetylprocainamide (NAPA) was detected, with levels generally lower than procainamide.
- One patient with an overdose showed altered kinetics due to hypotension.
Conclusions:
- The rapid clearance and short half-life of procainamide in children necessitate careful dosing strategies.
- Continuous intravenous infusion might be required to achieve and maintain therapeutic procainamide plasma concentrations in pediatric patients.
Abstract:
Procainamide kinetics were studied in six children after a single intravenous dose. Two-compartment kinetic analysis of serum concentration-time curves of five children, who received a dose of 5.5 +/- 0.9 mg/kg (mean +/- SD), revealed the following values for kinetic parameters: distribution half-life, 10.3 +/- 3.4 min; elimination half-life, 1.7 +/- 0.1 hr; elimination constant, 1.2 +/- 0.3 hr-1; plasma clearance 19.4 +/- 2.0 ml/min/kg, and steady-state volume of distribution, 2.2 +/- 0.3 l/kg. A sixth patient, who received an accidental overdose of 28 mg/kg, had altered elimination kinetics due to drug-induced hypotension. N-acetylprocainamide (NAPA) was detected in serum samples obtained soon after procainamide dosing and peak concentrations were attained at 1 to 2 hr. NAPA levels were lower than corresponding procainamide concentrations at most sampling periods. The findings of short elimination half-life and rapid plasma clearance of procainamide in children suggest that continuous intravenous infusion may be necessary to maintain therapeutically effective plasma concentrations in these patients.